Towards human ex vivo organ perfusion models to elucidate drug pharmacokinetics in health and disease

References

• Abe N, Kato S, Tsuchida T, Sugimoto K, Saito R, Verschuren L, Kleemann R, Oka K. 2019. Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients. Biol Open. 8(5):bio041251.
   PubMed Web of Science ®Google Scholar
• Alam MA, Al-Jenoobi FI, Al-Mohizea AM. 2012. Everted gut sac model as a tool in pharmaceutical research: limitations and applications. J Pharm Pharmacol. 64(3):326–336.
   PubMed Web of Science ®Google Scholar
• Arakawa H, Kubo H, Washio I, Staub AY, Nedachi S, Ishiguro N, Nakanishi T, Tamai I. 2019. Rat Kidney Slices for Evaluation of Apical Membrane Transporters in Proximal Tubular Cells. J Pharm Sci. 108(8):2798–2804.
   PubMed Web of Science ®Google Scholar
• Arakawa H, Washio I, Matsuoka N, Kubo H, Staub AY, Nakamichi N, Ishiguro N, Kato Y, Nakanishi T, Tamai I. 2017. Usefulness of kidney slices for functional analysis of apical reabsorptive transporters. Sci Rep. 7(1):12814.
   PubMed Web of Science ®Google Scholar
• Barthe L, Bessouet M, Woodley J, Houin G. 1998. The improved everted gut sac: a simple method to study intestinal P-glycoprotein. Int J Pharm. 173(1-2):255–258.
   Web of Science ®Google Scholar
• Bartucci R, Åberg C, Melgert BN, Boersma YL, Olinga P, Salvati A. 2020. Time-resolved quantification of nanoparticle uptake, distribution, and impact in precision-cut liver slices. Small (Weinheim an der Bergstrasse, Germany). 16:1906523.
   Web of Science ®Google Scholar
• Baverel G, Knouzy B, Gauthier C, El Hage M, Ferrier B, Martin G, Duplany A. 2013. Use of precision-cut renal cortical slices in nephrotoxicity studies. Xenobiotica. 43(1):54–62.
   PubMed Web of Science ®Google Scholar
• Bekersky I. 1983. Use of the isolated perfused kidney as a tool in drug disposition studies. Drug Metab Rev. 14(5):931–960.
   PubMed Web of Science ®Google Scholar
• Benet L, Cummins C, Wu C. 2003. Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data. Curr Drug Metab. 4(5):393–398.
   PubMed Web of Science ®Google Scholar
• Benet L, Cummins C, Wu C. 2004. Unmasking the dynamic interplay between efflux transporters and metabolic enzymes. Int J Pharm. 277(1-2):3–9.
   PubMed Web of Science ®Google Scholar
• Berginc K, Trontelj J, Kristl A. 2010. The influence of aged garlic extract on the uptake of saquinavir and darunavir into HepG2 cells and rat liver slices. Drug Metab Pharmacokinet. 25(3):307–313.
   PubMed Web of Science ®Google Scholar
• Bessems M, 't Hart N, Tolba R, Doorschodt B, Leuvenink H, Ploeg R, Minor T, Van Gulik T. 2006. The isolated perfused rat liver: standardization of a time-honoured model. Lab Anim. 40(3):236–246.
   PubMed Web of Science ®Google Scholar
• Bezençon J, Beaudoin JJ, Ito K, Fu D, Roth SE, Brock WJ, Brouwer KL. 2019. Altered Expression and Function of Hepatic Transporters in a Rodent Model of Polycystic Kidney Disease. Drug Metab Dispos. 47(8):899–906.
   PubMed Web of Science ®Google Scholar
• Bhadriraju K, Chen CS. 2002. Engineering cellular microenvironments to improve cell-based drug testing. Drug Discov Today. 7(11):612–620.
   PubMed Web of Science ®Google Scholar
• Bhise NS, Ribas J, Manoharan V, Zhang YS, Polini A, Massa S, Dokmeci MR, Khademhosseini A. 2014. Organ-on-a-chip platforms for studying drug delivery systems. J Control Release. 190:82–93.
   PubMed Web of Science ®Google Scholar
• Bilski J, Mazur-Bialy A, Wojcik D, Surmiak M, Magierowski M, Sliwowski Z, Pajdo R, Kwiecien S, Danielak A, Ptak-Belowska A, et al. 2019. Role of obesity, mesenteric adipose tissue, and adipokines in inflammatory bowel diseases. Biomolecules. 9(12):780.
   PubMed Web of Science ®Google Scholar
• Blokzijl H, Vander Borght S, Bok LIH, Libbrecht L, Geuken M, van den Heuvel FAJ, Dijkstra G, Roskams TAD, Moshage H, Jansen PLM, et al. 2007. Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels. Inflamm Bowel Dis. 13(6):710–720.
   PubMed Web of Science ®Google Scholar
• Blokzijl H, van Steenpaal A, Vander Borght S, Bok LIH, Libbrecht L, Tamminga M, Geuken M, Roskams TAD, Dijkstra G, Moshage H, et al. 2008. Up-regulation and cytoprotective role of epithelial multidrug resistance-associated protein 1 in inflammatory bowel disease. J Biol Chem. 283(51):35630–35637.
   PubMed Web of Science ®Google Scholar
• Boehnert MU, Yeung JC, Bazerbachi F, Knaak JM, Selzner N, McGilvray ID, Rotstein OD, Adeyi OA, Kandel SM, Rogalla P, et al. 2013. Normothermic acellular ex vivo liver perfusion reduces liver and bile duct injury of pig livers retrieved after cardiac death. Am J Transplantation. 13(6):1441–1449.
   PubMed Web of Science ®Google Scholar
• Booth CL, Brouwer KR, Brouwer KL. 1998. Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver. Cancer Res. 58(16):3641–3648.
   PubMed Web of Science ®Google Scholar
• Borie DC, Eyraud D, Boleslawski E, Lemoine A, Sebagh M, Cramer DV, Roussi J, Imbert-Bismut F, Germain G, Hannoun L. 2001. Functional metabolic characteristics of intact pig livers during prolonged extracorporeal perfusion: potential for a unique biological liver-assist device. Transplantation. 72(3):393–405.
   PubMed Web of Science ®Google Scholar
• Bridges JF. 1980. A study of macromolecule absorption in vitro by the small intestine of adult rats. Newcastle (UK): Keele University.
   Google Scholar
• Burks T, Long J. 1966. 5-Hydroxytryptamine release into dog intestinal vasculature. American Journal of Physiology-Legacy Content. 211(3):619–625.
   Google Scholar
• Butler AJ, Rees MA, Wight DG, Casey ND, Alexander G, White DJ, Friend PJ. 2002. Successful extracorporeal porcine liver perfusion for 72 hr1. Transplantation. 73(8):1212–1218.
   PubMed Web of Science ®Google Scholar
• Buyse M, Radeva G, Bado A, Farinotti R. 2005. Intestinal inflammation induces adaptation of P-glycoprotein expression and activity. Biochem Pharmacol. 69(12):1745–1754.
   PubMed Web of Science ®Google Scholar
• Chan LM, Lowes S, Hirst BH. 2004. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci. 21(1):25–51.
   PubMed Web of Science ®Google Scholar
• Chu X, Chan GH, Evers R. 2017. Identification of endogenous biomarkers to predict the propensity of drug candidates to cause hepatic or renal transporter-mediated drug-drug interactions. J Pharm Sci. 106(9):2357–2367.
   PubMed Web of Science ®Google Scholar
• Czerwinski M, Oberheide B, Hatfield N, Ewy B, Seib C, Gatineau E, Yiannikouris F, O’Brien M, Ogilvie BW. 2019. Microsomal cytochrome P450 enzyme activities in nonalcoholic steatohepatitis livers. Drug Metab Pharmacokinet. 34(1):S25.
   PubMed Web of Science ®Google Scholar
• Daga M, de Graaf IAM, Argenziano M, Barranco ASM, Loeck M, Al-Adwi Y, Cucci MA, Caldera F, Trotta F, Barrera G, et al. 2020. Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: evaluation of toxicity and transport mechanisms in the liver. Toxicol in Vitro. 65:104800.
   PubMed Web of Science ®Google Scholar
• Dawson A, Dyer C, Macfie J, Davies J, Karsai L, Greenman J, Jacobsen M. 2016. A microfluidic chip based model for the study of full thickness human intestinal tissue using dual flow. Biomicrofluidics. 10(6):064101.
   PubMed Web of Science ®Google Scholar
• De Graaf IA, Olinga P, De Jager MH, Merema MT, De Kanter R, Van De Kerkhof EG, Groothuis GM. 2010. Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nat Protoc. 5(9):1540–1551.
   PubMed Web of Science ®Google Scholar
• de Vries MH, Rademaker CM, Geerlings C, Van Dijk A, Noordhoek J. 1989. Pharmacokinetic modelling of the effect of activated charcoal on the intestinal secretion of theophylline, using the isolated vascularly perfused rat small intestine. J Pharm Pharmacol. 41(8):528–533.
   PubMed Web of Science ®Google Scholar
• de Vries Y, Matton APM, Nijsten MWN, Werner MJM, van den Berg AP, de Boer MT, Buis CI, Fujiyoshi M, de Kleine RHJ, van Leeuwen OB, et al. 2019. Pretransplant sequential hypo- and normothermic machine perfusion of suboptimal livers donated after circulatory death using a hemoglobin-based oxygen carrier perfusion solution. Am J Transplant. 19(4):1202–1211.
   PubMed Web of Science ®Google Scholar
• Eshmuminov D, Becker D, Bautista Borrego L, Hefti M, Schuler MJ, Hagedorn C, Muller X, Mueller M, Onder C, Graf R, et al. 2020. An integrated perfusion machine preserves injured human livers for 1 week. Nat Biotechnol. 38(2):189–198.
   PubMed Web of Science ®Google Scholar
• Estrada-Ortiz N, Guarra F, de Graaf IA, Marchetti L, de Jager MH, Groothuis GM, Gabbiani C, Casini A. 2017. Anticancer gold N-heterocyclic carbene complexes: a comparative in vitro and ex vivo study. ChemMedChem. 12(17):1429–1435.
   PubMed Web of Science ®Google Scholar
• Fabre G, Combalbert J, Berger Y, Cano J-P. 1990. Human hepatocytes as a key in vitro model to improve preclinical drug development. Eur J Drug Metab Pharmacokinet. 15(2):165–171.
   PubMed Web of Science ®Google Scholar
• Fagerholm U. 2008. Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation. J Pharm Pharmacol. 60(5):535–542.
   PubMed Web of Science ®Google Scholar
• Fleishaker JC, Smith RB. 1987. Compartmental model analysis in pharmacokinetics. J Clin Pharmacol. 27(12):922–926.
   PubMed Web of Science ®Google Scholar
• Fowler S, Chen K, Duignan D, Gupta A, Hariparsad N, Kenny JR, Lai G, Liras J, Phillips JA, Gan J. 2020. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization. Lab Chip. 20(3):446–467.
   PubMed Web of Science ®Google Scholar
• Fromm M. 2012. Prediction of transporter-mediated drug-drug interactions using endogenous compounds. Clin Pharmacol Ther. 92(5):546–548.
   PubMed Web of Science ®Google Scholar
• Gandia P, Lacombe O, Woodley J, Houin G. 2004. The perfused everted intestinal segment of rat. Arzneimittelforschung. 54(8):467–473.
   PubMed Web of Science ®Google Scholar
• George J, Murray M, Byth K, Farrell GC. 1995. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology. 21(1):120–128.
   PubMed Web of Science ®Google Scholar
• Ghibellini G, Leslie EM, Brouwer KL. 2006. Methods to evaluate biliary excretion of drugs in humans: an updated review. Mol Pharm. 3(3):198–211.
   PubMed Web of Science ®Google Scholar
• Gores GJ, Kost LJ, Larusso NF. 1986. The isolated perfused rat liver: conceptual and practical considerations. Hepatology. 6(3):511–517.
   PubMed Web of Science ®Google Scholar
• Guillouzo A. 1998. Liver cell models in in vitro toxicology. Environ Health Perspect. 106(suppl 2):511–532.
   PubMed Web of Science ®Google Scholar
• Haslam IS, O'Reilly DA, Sherlock DJ, Kauser A, Womack C, Coleman T. 2011. Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue. Biopharm Drug Dispos. 32(4):210–221.
   PubMed Web of Science ®Google Scholar
• Hori R, Okamura N, Aiba T, Tanigawara Y. 1993. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney. J Pharmacol Exp Ther. 266(3):1620–1625.
   PubMed Web of Science ®Google Scholar
• Hosgood S, Barlow A, Hunter J, Nicholson M. 2015. Ex vivo normothermic perfusion for quality assessment of marginal donor kidney transplants. Br J Surg. 102(11):1433–1440.
   PubMed Web of Science ®Google Scholar
• Hosgood SA, van Heurn E, Nicholson ML. 2015. Normothermic machine perfusion of the kidney: better conditioning and repair? Transpl Int. 28(6):657–664.
   PubMed Web of Science ®Google Scholar
• Ito K, Iwatsubo T, Kanamitsu S, Ueda K, Suzuki H, Sugiyama Y. 1998. Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver. Pharmacol Rev. 50(3):387–412.
   PubMed Web of Science ®Google Scholar
• Ito R, Takahashi T, Katano I, Ito M. 2012. Current advances in humanized mouse models. Cell Mol Immunol. 9(3):208–214.
   PubMed Web of Science ®Google Scholar
• Jablonski P, Doglas MC, Gordon E, Owen JA, Watts JM. 1971. Studies on the isolated perfused pig liver. Br J Surg. 58(2):129–137.
   PubMed Web of Science ®Google Scholar
• Jamieson RW, Zilvetti M, Roy D, Hughes D, Morovat A, Coussios CC, Friend PJ. 2011. Hepatic steatosis and normothermic perfusion—preliminary experiments in a porcine model. Transplantation. 92(3):289–295.
   PubMed Web of Science ®Google Scholar
• Jiménez-Castro M, Elias-Miró M, Casillas-Ramírez A, Peralta C. 2013. Experimental models in liver surgery. Hepatic Surgery. 6:121–166.
   Google Scholar
• Jones H, Rowland-Yeo K. 2013. Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development. CPT: Pharmacomet Syst Pharmacol. 2(8):e63–12.
   PubMedGoogle Scholar
• Jones NS, Yoshida K, Salphati L, Kenny JR, Durk MR, Chinn LW. 2020. Complex DDI by fenebrutinib and the use of transporter endogenous biomarkers to elucidate the mechanism of DDI. Clin Pharmacol Ther. 107(1):269–277.
   PubMed Web of Science ®Google Scholar
• Kanter R, Monshouwer M, Meijer D, Groothuis G. 2002. Precision-cut organ slices as a tool to study toxicity and metabolism of xenobiotics with special reference to non-hepatic tissues. Curr Drug Metab. 3(1):39–59.
   PubMed Web of Science ®Google Scholar
• Kasichayanula S, Boulton DW, Luo WL, Rodrigues AD, Yang Z, Goodenough A, Lee M, Jemal M, LaCreta F. 2014. Validation of 4β-hydroxycholesterol and evaluation of other endogenous biomarkers for the assessment of CYP3A activity in healthy subjects. Br J Clin Pharmacol. 78(5):1122–1134.
   PubMed Web of Science ®Google Scholar
• Katoh M, Sawada T, Soeno Y, Nakajima M, Tateno C, Yoshizato K, Yokoi T. 2007. In vivo drug metabolism model for human cytochrome P450 enzyme using chimeric mice with humanized liver. J Pharm Sci. 96(2):428–437.
   PubMed Web of Science ®Google Scholar
• Khong YM, Zhang J, Zhou S, Cheung C, Doberstein K, Samper V, Yu H. 2007. Novel intra-tissue perfusion system for culturing thick liver tissue. Tissue Eng. 13(9):2345–2356.
   PubMedGoogle Scholar
• Kim HJ, Huh D, Hamilton G, Ingber DE. 2012. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip. 12(12):2165–2174.
   PubMed Web of Science ®Google Scholar
• Krishna DR, Klotz U. 1994. Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet. 26(2):144–160.
   PubMed Web of Science ®Google Scholar
• Kusuhara H, Sugiyama Y. 2002. Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney. J Control Release. 78(1–3):43–54.
   PubMed Web of Science ®Google Scholar
• Lappin G, Noveck R, Burt T. 2013. Microdosing and drug development: past, present and future. Expert Opin Drug Metab Toxicol. 9(7):817–834.
   PubMed Web of Science ®Google Scholar
• Lau YY, Wu C-Y, Okochi H, Benet LZ. 2004. Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay. J Pharmacol Exp Ther. 308(3):1040–1045.
   PubMed Web of Science ®Google Scholar
• Lennernäs H. 2007. Animal data: the contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivo. Adv Drug Deliv Rev. 59(11):1103–1120.
   PubMed Web of Science ®Google Scholar
• Lentz KA. 2008. Current methods for predicting human food effect. Aaps J. 10(2):282–288.
   PubMed Web of Science ®Google Scholar
• Levine RR, McNary WF, Kornguth PJ, LeBlanc R. 1970. Histological reevaluation of everted gut technique for studying intestinal absorption. Eur J Pharmacol. 9(2):211–219.
   PubMed Web of Science ®Google Scholar
• Li AP. 2007. Human hepatocytes: isolation, cryopreservation and applications in drug development. Chem Biol Interact. 168(1):16–29.
   PubMed Web of Science ®Google Scholar
• Li M, de Graaf IA, Groothuis GM. 2016. Precision-cut intestinal slices: alternative model for drug transport, metabolism, and toxicology research. Expert Opin Drug Metab Toxicol. 12(2):175–190.
   PubMed Web of Science ®Google Scholar
• Lindahl A, Sandström R, Ungell AL, Lennernäs H. 1998. Concentration- and Region-dependent Intestinal Permeability of Fluvastatin in the Rat. J Pharm Pharmacol. 50(7):737–744.
   PubMed Web of Science ®Google Scholar
• Lipscomb JC, Poet TS. 2008. In vitro measurements of metabolism for application in pharmacokinetic modeling. Pharmacol Ther. 118(1):82–103.
   PubMed Web of Science ®Google Scholar
• Maeng HJ, Durk MR, Chow EC, Ghoneim R, Pang KS. 2011. 1α,25-dihydroxyvitamin D3 on intestinal transporter function: studies with the rat everted intestinal sac . Biopharm Drug Dispos. 32(2):112–125.
   PubMed Web of Science ®Google Scholar
• Maschmeyer I, Lorenz AK, Schimek K, Hasenberg T, Ramme AP, Hübner J, Lindner M, Drewell C, Bauer S, Thomas A, et al. 2015. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip. 15(12):2688–2699.
   PubMed Web of Science ®Google Scholar
• Meekel JP, Groeneveld ME, Bogunovic N, Keekstra N, Musters RJP, Zandieh-Doulabi B, Pals G, Micha D, Niessen HWM, Wiersema AM, et al. 2018. An in vitro method to keep human aortic tissue sections functionally and structurally intact. Sci Rep. 8(1):1–12.
   PubMed Web of Science ®Google Scholar
• Melgert BN, Olinga P, Weert B, Slooff MJ, Meijer DK, Poelstra K, Groothuis GM. 2001. Cellular distribution and handling of liver-targeting preparations in human livers studied by a liver lobe perfusion. Drug Metab Dispos. 29(6):361–367.
   Web of Science ®Google Scholar
• Midwoud, P. M. V. (2010). An alternative approach based on microfluidics to study drug metabolism and toxicity using liver and intestinal tissue [dissertation]. Groningen: s.n.
   Google Scholar
• Mooij MG, van Duijn E, Knibbe CA, Allegaert K, Windhorst AD, van Rosmalen J, Hendrikse NH, Tibboel D, Vaes WH, de Wildt SN. 2017. Successful Use of [14C]Paracetamol Microdosing to Elucidate Developmental Changes in Drug Metabolism. Clin Pharmacokinet. 56(10):1185–1195.
   PubMed Web of Science ®Google Scholar
• Morrison MC, Kleemann R, van Koppen A, Hanemaaijer R, Verschuren L. 2018. Key inflammatory processes in human NASH are reflected in Ldlr-/-.Leiden Mice: A Translational Gene Profiling Study. Front Physiol. 9:132.
   PubMed Web of Science ®Google Scholar
• Müller F, Fromm MF. 2011. Transporter-mediated drug-drug interactions. Pharmacogenomics. 12(7):1017–1037.
   PubMed Web of Science ®Google Scholar
• Musther H, Olivares-Morales A, Hatley OJ, Liu B, Hodjegan AR. 2014. Animal versus human oral drug bioavailability: do they correlate? Eur J Pharm Sci. 57:280–291.
   PubMed Web of Science ®Google Scholar
• Nicholson ML, Hosgood S. 2013. Renal transplantation after ex vivo normothermic perfusion: the first clinical study. Am J Transplant. 13(5):1246–1252.
   PubMed Web of Science ®Google Scholar
• Nishiitsutsuji-Uwo J, Ross B, Krebs H. 1967. Metabolic activities of the isolated perfused rat kidney. Biochem J. 103(3):852–862.
   PubMed Web of Science ®Google Scholar
• OrganAssist. n.d. [accessed]. https://www.organ-assist.nl/products/liver-assist/.
   Google Scholar
• Organox. n.d. [accessed]. https://www.organox.com/.
   Google Scholar
• Orlando R, Floreani M, Napoli E, Padrini R, Palatini P. 2000. Renal clearance of N1-methylnicotinamide: A sensitive marker of the severity of liver dysfunction in cirrhosis. Nephron. 84(1):32–39.
   PubMed Web of Science ®Google Scholar
• O'Sullivan D, Brosnan TJ, Brosnan EM. 1998. Hepatic zonation of the catabolism of arginine and ornithine in the perfused rat liver. Biochem J. 330(2):627–632.
   PubMed Web of Science ®Google Scholar
• Palatini P, De Martin S. 2016. Pharmacokinetic drug interactions in liver disease: an update. World J Gastroenterol. 22(3):1260–1278.
   PubMed Web of Science ®Google Scholar
• Pang KS, Koster H, Halsema I, Scholtens E, Mulder GJ, Stillwell R. 1983. Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation. J Pharmacol Exp Ther. 224(3):647–653.
   PubMed Web of Science ®Google Scholar
• Pang KS, Rowland M. 1977. Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm. 5(6):625–653.
   PubMedGoogle Scholar
• Parrish AR, Gandolfi AJ, Brendel K. 1995. Precision-cut tissue slices: applications in pharmacology and toxicology. Life Sci. 57(21):1887–1901.
   PubMed Web of Science ®Google Scholar
• Pfeifer ND, Yang K, Brouwer KL. 2013. Hepatic basolateral efflux contributes significantly to rosuvastatin disposition I: characterization of basolateral versus biliary clearance using a novel protocol in sandwich-cultured hepatocytes. J Pharmacol Exp Ther. 347(3):727–736.
   PubMed Web of Science ®Google Scholar
• Possidente M, Dragoni S, Franco G, Gori M, Bertelli E, Teodori E, Frosini M, Valoti M. 2011. Rat intestinal precision-cut slices as an in vitro model to study xenobiotic interaction with transporters. Eur J Pharm Biopharm. 79(2):343–348.
   PubMed Web of Science ®Google Scholar
• Prasad N, Bhasker S. 2012. Characterization of intestinal transport of Vincristine in rats applying in situ single pass intestinal perfusion. Pharmacologia. 3(11):617–621.
   Google Scholar
• Reidenberg MM, Odar-Cederlöf I, von Bahr C, Borgå O, Sjöqvist F. 1971. Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. N Engl J Med. 285(5):264–267.
   PubMed Web of Science ®Google Scholar
• Renwick AB, Watts PS, Edwards RJ, Barton PT, Guyonnet I, Price RJ, Tredger JM, Pelkonen O, Boobis AR, Lake BG. 2000. Differential maintenance of cytochrome P450 enzymes in cultured precision-cut human liver slices. Drug Metab Dispos. 28(10):1202–1209.
   PubMed Web of Science ®Google Scholar
• Rodrigues A, Taskar K, Kusuhara H, Sugiyama Y. 2018. Endogenous probes for drug transporters: balancing vision with reality. Clin Pharmacol Ther. 103(3):434–448.
   PubMed Web of Science ®Google Scholar
• Rodriguez AD, Horowitz LF, Castro K, Kenerson H, Bhattacharjee N, Gandhe G, Raman A, Monnat RJ, Yeung R, Rostomily RC, et al. 2020. A microfluidic platform for functional testing of cancer drugs on intact tumor slices. Lab Chip. 20(9):1658–1675.
   PubMed Web of Science ®Google Scholar
• Roeselers G, Ponomarenko M, Lukovac S, Wortelboer HM. 2013. Ex vivo systems to study host-microbiota interactions in the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 27(1):101–113.
   PubMed Web of Science ®Google Scholar
• Rowland M, Benet LZ, Graham GG. 1973. Clearance concepts in pharmacokinetics. J Pharmacokinet Biopharm. 1(2):123–136.
   PubMedGoogle Scholar
• Rozehnal V, Nakai D, Hoepner U, Fischer T, Kamiyama E, Takahashi M, Yasuda S, Mueller J. 2012. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs. Eur J Pharm Sci. 46(5):367–373.
   PubMed Web of Science ®Google Scholar
• Salam M, Keeffe EB. 1989. Liver cysts associated with polycystic kidney disease: role of Tc-99m hepatobiliary imaging. Clin Nucl Med. 14(11):803–807.
   PubMed Web of Science ®Google Scholar
• Santos C, Jacob J, Hertzog B, Freedman B, Press D, Harnpicharnchai P, Mathiowitz E. 1999. Correlation of two bioadhesion assays: the everted sac technique and the CAHN microbalance. J Controlled Release. 61(1-2):113–122.
   PubMed Web of Science ®Google Scholar
• Sato T, Clevers H. 2013. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science. 340(6137):1190–1194.
   PubMed Web of Science ®Google Scholar
• Schanker LS, Tocco DJ, Brodie BB, Hogben C. 1958. Absorption of drugs from the rat small intestine. J Pharmacol Exp Ther. 123(1):81–88.
   PubMed Web of Science ®Google Scholar
• Schary WL, Rowland M. 1983. Protein binding and hepatic clearance: studies with tolbutamide, a drug of low intrinsic clearance, in the isolated perfused rat liver preparation. J Pharmacokinet Biopharm. 11(3):225–243.
   PubMedGoogle Scholar
• Schreiter T, Marquitan G, Darnell M, Sowa J-P, Bröcker-Preuss M, Andersson TB, Baba HA, Furch M, Arteel GE, Mathé Z, et al. 2012. An ex vivo perfusion system emulating in vivo conditions in noncirrhotic and cirrhotic human liver. J Pharmacol Exp Ther. 342(3):730–741.
   PubMed Web of Science ®Google Scholar
• Schreiter T, Sowa J-P, Schlattjan M, Treckmann J, Paul A, Strucksberg K-H, Baba HA, Odenthal M, Gieseler RK, Gerken G, et al. 2016. Human ex-vivo liver model for acetaminophen-induced liver damage. Sci Rep. 6:31916.
   PubMed Web of Science ®Google Scholar
• Schumacher K, Khong Y-M, Chang S, Ni J, Sun W, Yu H. 2007. Perfusion culture improves the maintenance of cultured liver tissue slices. Tissue Eng. 13(1):197–205.
   PubMedGoogle Scholar
• Shand DG, Cotham RH, Wilkinson GR. 1976. Perfusion-limited effects of plasma drug binding on hepatic drug extraction. Life Sci. 19(1):125–130.
   PubMed Web of Science ®Google Scholar
• Shanks N, Greek R, Greek J. 2009. Are animal models predictive for humans? Philos Ethics Humanit Med. 4(1):2.
   PubMedGoogle Scholar
• Shen H, Dai J, Liu T, Cheng Y, Chen W, Freeden C, Zhang Y, Humphreys WG, Marathe P, Lai Y. 2016. Coproporphyrins I and III as functional markers of OATP1B activity: in vitro and in vivo evaluation in preclinical species. J Pharmacol Exp Ther. 357(2):382–393.
   PubMed Web of Science ®Google Scholar
• Shitara Y, Sato H, Sugiyama Y. 2005. Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs. Annu Rev Pharmacol Toxicol. 45:689–723.
   PubMed Web of Science ®Google Scholar
• Singh SS. 2006. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Curr Drug Metab. 7(2):165–182.
   PubMed Web of Science ®Google Scholar
• Sjöberg Å, Lutz M, Tannergren C, Wingolf C, Borde A, Ungell A-L. 2013. Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique. Eur J Pharm Sci. 48(1-2):166–180.
   PubMed Web of Science ®Google Scholar
• Spreckelmeyer S, Estrada-Ortiz N, Prins GG, Van Der Zee M, Gammelgaard B, Stürup S, De Graaf IA, Groothuis GM, Casini A. 2017. On the toxicity and transport mechanisms of cisplatin in kidney tissues in comparison to a gold-based cytotoxic agent. Metallomics. 9(12):1786–1795.
   PubMed Web of Science ®Google Scholar
• Stappaerts J, Brouwers J, Annaert P, Augustijns P. 2015. In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunities. Int J Pharm. 478(2):665–681.
   PubMed Web of Science ®Google Scholar
• Stevens LJ, van Lipzig MM, Erpelinck SL, Pronk A, van Gorp J, Wortelboer HM, van de Steeg E. 2019. A higher throughput and physiologically relevant two-compartmental human ex vivo intestinal tissue system for studying gastrointestinal processes. Eur J Pharm Sci. 137:104989.
   PubMed Web of Science ®Google Scholar
• Stollman YR, Gärtner U, Theilmann L, Ohmi N, Wolkoff AW. 1983. Hepatic bilirubin uptake in the isolated perfused rat liver is not facilitated by albumin binding. J Clin Invest. 72(2):718–723.
   PubMed Web of Science ®Google Scholar
• Swart P, Lozac'h F, Simon M, van Duijn E, Vaes WHJ. 2016. The impact of early human data on clinical development: there is time to win. Drug Discov Today. 21(6):873–879.
   PubMed Web of Science ®Google Scholar
• Swift B, Pfeifer ND, Brouwer KL. 2010. Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev. 42(3):446–471.
   PubMed Web of Science ®Google Scholar
• Tsamandouras N, Chen WLK, Edington CD, Stokes CL, Griffith LG, Cirit M. 2017. Integrated gut and liver microphysiological systems for quantitative in vitro pharmacokinetic studies. Aaps J. 19(5):1499–1512.
   PubMed Web of Science ®Google Scholar
• Tsao SC, Sugiyama Y, Sawada Y, Iga T, Hanano M. 1988. Kinetic analysis of albumin-mediated uptake of warfarin by perfused rat liver. J Pharmacokinet Biopharm. 16(2):165–181.
   PubMedGoogle Scholar
• Troth SP, Simutis F, Friedman GS, Todd S, Sistare FD. 2019. Kidney safety assessment: current practices in drug development. Seminars Nephrol. 39(2):120–131.
   PubMed Web of Science ®Google Scholar
• Vaessen SF, van Lipzig MM, Pieters RH, Krul CA, Wortelboer HM, van de Steeg E. 2017. Regional expression levels of drug transporters and metabolizing enzymes along the pig and human intestinal tract and comparison with Caco-2 cells. Drug Metab Dispos. 45(4):353–360.
   PubMed Web of Science ®Google Scholar
• Van Crugten JT, Sallustio BC, Nation RL, Somogyi AA. 1991. Renal tubular transport of morphine, morphine-6-glucuronide, and morphine-3-glucuronide in the isolated perfused rat kidney. Drug Metab Dispos. 19(6):1087–1092.
   PubMed Web of Science ®Google Scholar
• van de Kerkhof EG, de Graaf IA, Ungell A-L, Groothuis GM. 2008. Induction of metabolism and transport in human intestine: validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro. Drug Metab Dispos. 36(3):604–613.
   PubMed Web of Science ®Google Scholar
• van de Steeg E, Schuren FH, Obach RS, van Woudenbergh C, Walker GS, Heerikhuisen M, Nooijen IH, Vaes WH. 2018. An ex vivo fermentation screening platform to study drug metabolism by human gut microbiota. Drug Metab Dispos. 46(11):1596–1607.
   PubMed Web of Science ®Google Scholar
• van de Steeg E, Stránecký V, Hartmannová H, Nosková L, Hřebíček M, Wagenaar E, van Esch A, de Waart DR, Oude Elferink RPJ, Kenworthy KE, et al. 2012. Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest. 122(2):519–528.
   PubMed Web of Science ®Google Scholar
• van de Steeg E, Wagenaar E, van der Kruijssen CM, Burggraaff JE, de Waart DR, Elferink RPO, Kenworthy KE, Schinkel AH. 2010. Organic anion transporting polypeptide 1a/1b–knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs. J Clin Invest. 120(8):2942–2952.
   PubMed Web of Science ®Google Scholar
• Van Ginneken C, Russel F. 1989. Saturable pharmacokinetics in the renal excretion of drugs. Clin Pharmacokinet. 16(1):38–54.
   PubMed Web of Science ®Google Scholar
• van Groen BD, Vaes WH, Park BK, Krekels EHJ, van Duijn E, Kõrgvee L-T, Maruszak W, Grynkiewicz G, Garner RC, Knibbe CAJ, et al. 2019. Dose-linearity of the pharmacokinetics of an intravenous [14 C]midazolam microdose in children . Br J Clin Pharmacol. 85(10):2332–2340.
   PubMed Web of Science ®Google Scholar
• Vickers AE, Fisher RL. 2005. Precision-cut organ slices to investigate target organ injury. Expert Opin Drug Metab Toxicol. 1(4):687–699.
   PubMedGoogle Scholar
• Villeneuve J-P, Dagenais M, Huet P-M, Lapointe R, Roy A, Marleau D. 1996. Clearance by the liver in cirrhosis. III. Propranolol uptake by the isolated perfused human liver. Can J Physiol Pharmacol. 74(12):1327–1332.
   PubMed Web of Science ®Google Scholar
• Villeneuve JP, Huet PM, Gariepy L, Fenyves D, Willems B, Côté J, Lapointe R, Marleau D. 1990. Isolated perfused cirrhotic human liver obtained from liver transplant patients: a feasibility study. Hepatology. 12(2):257–263.
   PubMed Web of Science ®Google Scholar
• Vogel T, Brockmann JG, Friend PJ. 2010. Ex-vivo normothermic liver perfusion: an update. Curr Opin Organ Transplant. 15(2):167–172.
   PubMed Web of Science ®Google Scholar
• Vogel T, Brockmann JG, Pigott D, Neil DA, Muthusamy ASR, Coussios CC, Friend PJ. 2017. Successful transplantation of porcine liver grafts following 48-hour normothermic preservation. PLOS One. 12(11):e0188494.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhou M-T, Chen C-Y, Yin W, Wen D-X, Cheung C-W, Yang L-Q, Yu W-F. 2017. Increased renal clearance of rocuronium compensates for chronic loss of bile excretion, via upregulation of Oatp2. Sci Rep. 7:40438.
   PubMed Web of Science ®Google Scholar
• Watson CJE, Kosmoliaptsis V, Pley C, Randle L, Fear C, Crick K, Gimson AE, Allison M, Upponi S, Brais R, et al. 2018. Observations on the ex situ perfusion of livers for transplantation. Am J Transplant. 18(8):2005–2020.
   PubMed Web of Science ®Google Scholar
• Wendler A, Wehling M. 2010. The translatability of animal models for clinical development: biomarkers and disease models. Curr Opin Pharmacol. 10(5):601–606.
   PubMed Web of Science ®Google Scholar
• Westerhout J, van de Steeg E, Grossouw D, Zeijdner EE, Krul CA, Verwei M, Wortelboer HM. 2014. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices. Eur J Pharm Sci. 63:167–177.
   PubMed Web of Science ®Google Scholar
• Westra I. 2014. Precision-cut liver slices: an ex vivo model for the early onset and end-stage of liver fibrosis [dissertation]. [S.l.]: s.n. p. 134.
   Google Scholar
• Wilson TH, Wiseman G. 1954. The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface. J Physiol. 123(1):116–125.
   PubMed Web of Science ®Google Scholar
• Yoshikawa R, Matsuno N, Morito N, Gouchi M, Otani M, Takahashi H, Shonaka T, Nishikawa Y, Enosawa S, Hirano T, et al. 2018. Evaluation using an isolated reperfusion model for porcine liver donated after cardiac death preserved with oxygenated hypothermic machine perfusion. Ann Transplant. 23:822–827.
   PubMed Web of Science ®Google Scholar
• Yu J, Ritchie TK, Mulgaonkar A, Ragueneau-Majlessi I. 2014. Drug disposition and drug-drug interaction data in 2013 FDA new drug applications: a systematic review. Drug Metab Dispos. 42(12):1991–2001.
   PubMed Web of Science ®Google Scholar
• Yum K, Hong SG, Healy KE, Lee LP. 2014. Physiologically relevant organs on chips. Biotechnol J. 9(1):16–27.
   PubMed Web of Science ®Google Scholar
• Zhang D, Luo G, Ding X, Lu C. 2012. Preclinical experimental models of drug metabolism and disposition in drug discovery and development. Acta Pharmaceutica Sinica B. 2(6):549–561.
   Google Scholar
• Zhu J. 2020. Application of Organ-on-Chip in Drug Discovery. JBM. 08(03):119–134.
   Google Scholar
• Zollner G, Fickert P, Silbert D, Fuchsbichler A, Marschall H-U, Zatloukal K, Denk H, Trauner M. 2003. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol. 38(6):717–727.
   PubMed Web of Science ®Google Scholar